Filing Flows › DBV Technologies S.A. (DBVT) › Recalls, complaints & regulation

DBV Technologies S.A. (DBVT): clinical trials

DBV Technologies S.A. (DBVT) beyond its filings: 3 active clinical trials.

DBV Technologies S.A.'s latest quarter

DBV Technologies S.A., Q3 2026: revenue $1.6M (-43% year over year), net loss $64.5M, operating cash flow −$51.5M. The chart follows the revenue to costs, profit and cash.

Questions

How many clinical trials does DBV Technologies S.A. have?

3 active studies on ClinicalTrials.gov, 3 in phase 3.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.